These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8548764)

  • 1. Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines.
    Tsai CM; Chang KT; Wu LH; Chen JY; Gazdar AF; Mitsudomi T; Chen MH; Perng RP
    Cancer Res; 1996 Jan; 56(1):206-9. PubMed ID: 8548764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin.
    Zhang L; Hung MC
    Oncogene; 1996 Feb; 12(3):571-6. PubMed ID: 8637714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
    Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
    Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
    Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPI-anchored molecule-like protein (GML) expression in non-small cell lung cancer (NSCLC).
    Komiya T; Hirashima T; Kikui M; Fukuoka M; Ohno A; Kawase I
    Anticancer Res; 1999; 19(5B):4315-9. PubMed ID: 10628393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
    Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.
    Tsai CM; Chang KT; Perng RP; Mitsudomi T; Chen MH; Kadoyama C; Gazdar AF
    J Natl Cancer Inst; 1993 Jun; 85(11):897-901. PubMed ID: 8098377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.
    Bodner SM; Minna JD; Jensen SM; D'Amico D; Carbone D; Mitsudomi T; Fedorko J; Buchhagen DL; Nau MM; Gazdar AF
    Oncogene; 1992 Apr; 7(4):743-9. PubMed ID: 1565469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer.
    Wu WG; Soria JC; Wang L; Kemp BL; Mao L
    Anticancer Res; 2000; 20(6B):4525-9. PubMed ID: 11205299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z; Ma J; Li N; Sun N; Wang C
    Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation arrest in G1 phase of a non-small cell lung cancer cell line (NSCLC-N6) treated by an original compound methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate (VT1) independently of the p53/p21 cascade.
    Jacquot C; Moreau D; Tomasoni C; Juge M; Coiffard L; Roussis V; Roussakis C
    Int J Oncol; 2003 Aug; 23(2):495-501. PubMed ID: 12851701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient stabilization of p53 in non-small cell lung carcinoma cultures arrested for growth by retinoic acid.
    Maxwell SA; Mukhopadhyay T
    Exp Cell Res; 1994 Sep; 214(1):67-74. PubMed ID: 8082749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
    Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G
    Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of features of human lung cancer cell lines and their corresponding tumors.
    Wistuba II; Bryant D; Behrens C; Milchgrub S; Virmani AK; Ashfaq R; Minna JD; Gazdar AF
    Clin Cancer Res; 1999 May; 5(5):991-1000. PubMed ID: 10353731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.